Catheter Precision, Inc., a medical device company focused on electrophysiology products, issued a press release on June 12, 2025, to address recent increases in trading activity of its common stock.

Precision Drilling's Q3 report shows strong performance in Canada, where rig demand is at multiyear highs. While the U.S. market remains a weakness, Precision Drilling is generating adequate margins ...

Medtronic Plc is partnering with brain implant company Precision Neuroscience Corp. in a deal that will give the medical ...

Precision BioSciences Presents Late-Breaking Phase 1 PBGENE-HBV Data at AASLD The Liver Meeting® Showing Safety, Tolerability and Cumulative, Dose-Dependent Antiviral Activity in First Three Cohorts ...

Antimicrobial resistance and ecological disruption caused by broad-spectrum disinfectants have created an urgent need for precision strategies that remove harmful bacteria without damaging beneficial ...

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need ...

PBGENE-HBV, the first gene editing therapy designed to treat chronic Hepatitis B by directly targeting HBV cccDNA and integrated HBV DNA, showcased as the final oral presentation in the late-breaking ...